Rethinking ‘carriage’ of take-home naloxone
Apr. 15, 2021 3:37 PM
In a new article, SERAF researchers Desiree Eide and Thomas Clausen, in collaboration with King's College, suggest improvements to research methods regarding "take home" naloxone (THN).
In Norway naloxone nasal spray is distributed under the auspices of SERAF on behalf of the Norwegian Directorate of Health as part of a national overdose strategy ( Nalokson.org). Naloxone nasal spray is an antidote treatment for opioid overdose.
Somatic disease burdens among ageing, long-term opioid maintenance treatment patients
Nov. 19, 2020 10:14 AM
In a recently published article, researchers at SERAF and NIPH together with the user organization proLAR-Nett, have investigated the somatic disease burden for aging long-term patients in OMT.
COVID-19 among drug users in Norway
Oct. 13, 2020 10:13 AM
Researchers at SERAF and partners have recently published an article on COVID-19 among drug users in the downtown environments of Oslo, Bergen and Kristiansand.